Despite significantly investing in their patient support programs and even letting an agency develop a custom app, drop off rates especially in the first 3 months of therapy remained unsatisfactory. The team had no data on why this was happening. Also programs were siloed by drug and country so the business unit could not realize any synergies across their portfolio.
We translated the content of the patient support program into dialog and connected Ariana to the patients directly over their preferred messenger. No download was required and the conversation with Ariana showed up next to friends and family. Working as the patients’ personal coach, Ariana offered disease and drug information, set reminders, answered questions and collected patient reported outcomes. To improve engagement and adherence, Ariana profiled the patients regarding their adherence type, behaviors and preferences. Based on this profile, she delivered a personally tailored program to each patient and kept track of their progress.
Adding Ariana to the existing patient support program
provided each patient with personal support tailored to their needs
delivered daily engagement and reduced 3 month drop off rates by 20%
created data transparency on patient behavior, reasons for non adherence, and patient reported outcomes
Now the pharma company is considering rolling out the Ariana platform across their biologics portfolio and feeding back the outcomes data into their pricing and reimbursement discussions.